Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÁøÇàµÈ ±¸°­¾ÏÀÇ Ç×¾ÏÈ­Çпä¹ý¿¡ ´ëÇÑ ÀÓ»óÀû ¿¬±¸

Clinical studies on the chemotherapy in advanced oral cancer patients

´ëÇѱ¸°­¾Ç¾È¸é¿Ü°úÇÐȸÁö 1993³â 19±Ç 1È£ p.12 ~ 21
±è¼ö°ü, À̼±ÁÖ,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¼ö°ü (  ) - Á¶¼±´ëÇб³ Àǰú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
À̼±ÁÖ (  ) - Á¶¼±´ëÇб³

Abstract


Twelve patients with advanced oral cancers were treated with a combination chemotherapy consisting of cisplatin, vincristine, bleomycin before definitive therapy.
There were 7(58%) partial and 2(17%) complete responders, with an overall response rate of 75%.
This regimen was well tolerated in spite of its toxicities as nausea, vomiting, alopecia, fever and nephrotoxicity.
The toxicities were managed symptomatically with antiemetic drugs, hydrocortisone, reduction of doses.

Ű¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed